Quantbot Technologies LP Revolution Medicines, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$17.46 - $26.0 $199,253 - $296,712	-11,412 Reduced 91.94%	1,000 $19,000
Q2 2022 Aug 09, 2022	SELL	$14.54 - $27.17 $20,181 - $37,711	-1,388 Reduced 10.06%	12,412 $241,000
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $204,257 - $311,520	11,800 Added 590.0%	13,800 $352,000
Q4 2021 Feb 11, 2022	BUY	$24.35 - $33.7 $48,700 - $67,400	2,000 New	2,000 $50,000
Q3 2021 Nov 09, 2021	SELL	$23.95 - $33.41 $26,345 - $36,750	-1,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$29.0 - $47.44 $31,900 - $52,184	1,100 New	1,100 $34,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.